Strategic Medical Brokers, LLC
Strategic Medical Brokers is a Phoenix-based medical-practice brokerage and transaction advisory firm. Its stated services include valuation, confidential marketing, buyer representation, exit planning, negotiation, funding support, and transition guidance for healthcare-practice transactions.
What stands out about Strategic Medical Brokers, LLC
Strategic Medical Brokers publicly describes a confidential brokerage model for medical-practice sales and acquisitions. Its stated process includes consultation, valuation, marketing, negotiation, and closing facilitation, with stated focus on healthcare practices generating between $1MM and $10MM in revenue.[1][2][3][4][5]
What does Strategic Medical Brokers, LLC do?
Strategic Medical Brokers is the official brand of a Phoenix-based medical-practice brokerage serving healthcare professionals. The firm publicly describes services for selling and acquiring medical practices and presents itself as an independent firm rather than part of a national franchise.[1][9]
Publicly stated services include medical-practice valuation, confidential marketing, buyer representation, exit planning, negotiation, funding support, and transition guidance. The firm’s stated sale process includes an initial consultation, practice valuation, marketing and promotion, negotiation, and closing facilitation.[1][3]
Owners comparing intermediaries can also review Auxo’s business broker, M&A advisor and investment bank comparison, advisor-selection guide, and M&A advisor fee guide.
Published criteria: The firm states that it specializes in selling healthcare practices with revenues between $1MM and $10MM. This is presented as a stated specialization rather than an absolute eligibility rule.[1]
What should a business owner evaluate before hiring Strategic Medical Brokers, LLC?
Owners evaluating Strategic Medical Brokers can examine its stated valuation, confidential marketing, buyer representation, negotiation, funding support, and transition guidance services. The firm’s public archive also provides examples across family medicine, pediatrics, dermatology, and other healthcare categories.
The official medical-practice sale process page does not publish a universal commission percentage, minimum fee, retainer, termination provision, or tail period. The recently-sold archive does not disclose final consideration, buyer identity, closing date, or financing terms for its listed examples. Sellers should request those details, along with the firm’s role and results in comparable completed transactions, before engagement.[1][3][5]
Which recent transactions were sold, and what were the asking price, final consideration, buyer type, financing structure, and closing date
How does the firm screen physician, strategic, MSO, private-equity, and other buyers
Does the firm or any affiliate hold licenses or registrations required for the specific services offered in the seller’s state
What size transactions does Strategic Medical Brokers, LLC handle?
The official recently-sold archive identifies examples including a turnkey pediatric practice associated with the Privia Health platform, a Columbus walk-in family practice, a cosmetic dermatology practice in the Texas Panhandle, and a pediatric practice in Fort Worth.
Additional sold listings identify an established family medicine practice with 5,000 active patients, an established family medicine practice with a building, and a turnkey family medicine practice in Aggieland. The listings describe asking prices and selected operating metrics; those figures are not presented here as final transaction consideration.[5][6][7][8]
The firm’s public offering covers both selling and acquiring medical practices. For buyers, it states that it uses buyer goals, preferred practice type, location, specialty focus, and growth potential to identify and evaluate acquisition opportunities.[1][4]
Strategic Medical Brokers states that it specializes in healthcare and medical-practice transactions. Its stated areas of focus include specialty practices, urgent care centers, larger facilities, and dental practices.
The firm lists locations in Arizona, Florida, and Texas and states that it connects sellers with qualified buyers nationwide.[1]
What does Strategic Medical Brokers, LLC publicly disclose about fees and engagement terms?
The official medical-practice sale process page describes services and process steps but does not publish a universal brokerage commission percentage, minimum fee, retainer, termination provision, or tail period.
The official recently-sold archive identifies sold practices and selected operating metrics but does not disclose final consideration, buyer identity, closing date, or financing terms for the listed examples.[3][5]
An Arizona Department of Real Estate record lists STRATEGIC MEDICAL BROKERS LLC as an active Real Estate Limited Liability entity under license LC723792000, with an original date of September 1, 2026 and an expiration date of September 30, 2028. The record identifies Shaun Fraser Rudgear as the designated broker under real-estate broker license BR008458000, shown as active through June 30, 2028.[2]
Strategic Medical Brokers states that it is independent and not part of a national franchise. It describes a team approach covering valuation, marketing, and negotiation.[9]
Questions to ask before hiring Strategic Medical Brokers, LLC
Which recent transactions were sold, and what were the asking price, final consideration, buyer type, financing structure, and closing date?
How does the firm screen physician, strategic, MSO, private-equity, and other buyers?
Does the firm or any affiliate hold licenses or registrations required for the specific services offered in the seller’s state?
What transition support is included, and for how long?
Sources & research notes
- Official website / firm overview
- Identity / organization record
- Services / capabilities
- Investment approach
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Public Process
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.